Abstract
Despite universal neonatal vaccination being implemented in 1988, the prevalence of chronic hepatitis B (CHB) infection remains high in Hong Kong. With antiviral therapy being available for over two decades now, there should be a significant decline in liver-related complications of CHB patients, especially with regards to cirrhosis and decompensated cirrhosis (1).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
